국가: 독일
언어: 영어
출처: HMA (Heads of Medicines Agencies)
amoxicillin trihydrate 500 mg
Laboratoires Biove Arques
QJ01CA04
Powder for oral solution
amoxicillin
Chicken Broilers
2010-01-19
11604 BIOAMOXI Final renewal SPC September 2008 SPC Bioamoxi March 2008 p. 1 / 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BIOAMOXI 500 mg/g powder for oral solution for chicken 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Amoxicillin as amoxicillin trihydrate .....500 mg Excipient ................................................QS 1 g For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for oral solution. _Fine, almost white, homogenous powder. _ 4. CLINICAL PARTICULARS _4.1. TARGET SPECIES _ Broiler chickens. _ _ _ _ _4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ _ In broiler chickens: - At the group level where disease is present: prevention of clinical colibacillosis due to _Escherichia _ _coli_ susceptible to amoxicillin. _4.3. CONTRAINDICATIONS _ Do not use in animals known for their susceptibility to penicillin or other substances of the -lactam group. Do not use in lagomorphs such as rabbits, guinea-pigs, hamsters and gerbils. Do not use in ruminants and horses. Do not use in case of -lactam-resistance in _Escherichia coli_. _4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES _ See section 4.11. _4.5. SPECIAL PRECAUTIONS FOR USE _ _4.5.I) SPECIAL PRECAUTION FOR USE IN ANIMALS: _ Penicillins and cephalosporins may cause hypersensitivity following administration. Allergic reactions to these substances may occasionally be serious. 11604 BIOAMOXI Final renewal SPC September 2008 SPC Bioamoxi March 2008 p. 2 / 6 The use of BIOAMOXI should be based on susceptibility testing because of reported resistance (up to 50 %) in _Escherichia 전체 문서 읽기